Novavax posts third quarter loss but beats revenue expectations

By November 18, 2022Health

The Covid-19 vaccine maker reported a net loss of more than $169 million for the third quarter, compared to a loss of $322 million in the same period last year.

Spread the love
See also  Pregnancy Due Date Calculator

Leave a Reply